Status: current, Primitive. Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3520526014 | Neratinib (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3520527017 | Neratinib | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Neratinib | Is a | Quinoline | true | Inferred relationship | Some | ||
| Neratinib | Is a | Nitrile | true | Inferred relationship | Some | ||
| Neratinib | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Neratinib | Has disposition | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Neratinib | Is a | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Neratinib | Is a | Enzyme inhibitor | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Neratinib maleate | Is modification of | True | Neratinib | Inferred relationship | Some | |
| Neratinib only product | Has active ingredient | True | Neratinib | Inferred relationship | Some | 1 |
| Neratinib only product in oral dose form | Has active ingredient | True | Neratinib | Inferred relationship | Some | 1 |
| Neratinib (as neratinib maleate) 40 mg oral tablet | Has BoSS | True | Neratinib | Inferred relationship | Some | 1 |
| Neratinib maleate | Is a | False | Neratinib | Inferred relationship | Some | |
| Neratinib-containing product | Has active ingredient | True | Neratinib | Inferred relationship | Some | 1 |
| Neratinib-containing product in oral dose form | Has active ingredient | True | Neratinib | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR